Literature DB >> 15456718

Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

M O Leach1, K M Brindle, J L Evelhoch, J R Griffiths, M R Horsman, A Jackson, G Jayson, I R Judson, M V Knopp, R J Maxwell, D McIntyre, A R Padhani, P Price, R Rathbone, G Rustin, P S Tofts, G M Tozer, W Vennart, J C Waterton, S R Williams, P Workman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15456718     DOI： 10.1259/bjr/15917261

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  33 in total

1.  Medical imaging in new drug clinical development.

Authors:  Yi-Xiang Wang; Min Deng
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

2.  An expectation-maximisation approach for simultaneous pixel classification and tracer kinetic modelling in dynamic contrast enhanced-magnetic resonance imaging.

Authors:  Mario Sansone; Roberta Fusco; Antonella Petrillo; Mario Petrillo; Marcello Bracale
Journal:  Med Biol Eng Comput       Date:  2010-11-03       Impact factor: 2.602

Review 3.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

4.  Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation.

Authors:  Lotte B Bertelsen; Yuan Yuan Shen; Thomas Nielsen; Hans Stødkilde-Jørgensen; G Kenneth Lloyd; Dietmar W Siemann; Michael R Horsman
Journal:  Int J Radiat Biol       Date:  2011-11       Impact factor: 2.694

5.  Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences.

Authors:  Matthias C Schabel; Dennis L Parker
Journal:  Phys Med Biol       Date:  2008-04-17       Impact factor: 3.609

6.  Magnetic Resonance Imaging for Drug Development.

Authors:  Jeong Kon Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  The impact of quantitative imaging in medicine and surgery: Charting our course for the future.

Authors:  Yi-Xiang J Wang; Chin K Ng
Journal:  Quant Imaging Med Surg       Date:  2011-12

8.  Molecular and clinical aspects of targeting the VEGF pathway in tumors.

Authors:  Grzegorz Korpanty; Laura A Sullivan; Elizabeth Smyth; Desmond N Carney; Rolf A Brekken
Journal:  J Oncol       Date:  2010-06-10       Impact factor: 4.375

9.  Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

Authors:  K K Y Cham; J H E Baker; K S Takhar; J A Flexman; M Q Wong; D A Owen; A Yung; P Kozlowski; S A Reinsberg; E M Chu; C-W A Chang; A K Buczkowski; S W Chung; C H Scudamore; A I Minchinton; D T T Yapp; S S W Ng
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

Review 10.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.